The FDA-approved Thermo Scientific Spot-Light HER2 CISH Kit is designed to allow users to perform an HER2 assay analogous to routine immunohistochemistry (IHC) that provides reliable gene status information and improves on the results obtained by fluorescent in situ hybridisation (FISH).
Current FDA-approved HER2 evaluation processes for screening breast cancer patients likely to respond to Herceptin therapy are FISH and IHC. The kit is claimed to have advantages to both of these methods.
Phone: 1800 331 627
Cayman Chemical Cellular Metabolism Screening Library
Cayman Chemical's Cellular Metabolism Screening Library consists of two plates and contains...
Navinci Diagnostics NaveniFlex Cell Red proximity ligation assay kit
Optimised for cell samples, the kit enables fluorescence visualisation of protein–protein...
Lonza TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium
The products provide researchers and manufacturers with high-performance, scalable and...
